Phathom Pharmaceuticals, Inc.
PHAT· Nasdaq
PHATPhathom Pharmaceuticals, Inc.
Filed Aug 6, 2020 · 10-Q · 37 days after period end · 0001564590-20-037296
| Metric | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|
| Net Income | -$21.10M | -$87.76M | -$260.00K |
| EPS Diluted | -$0.64 | -$13.11 | -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Aug 6, 2020 · 37 d after period end
